Gainers
- Akanda (NASDAQ:AKAN) stock increased by 28.2% to $0.36 during Thursday's after-market session. Akanda's trading volume hit 4.1 million shares by close, accounting for 474.8% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
- Lannett (NYSE:LCI) shares increased by 8.11% to $0.58. The market value of their outstanding shares is at $24.4 million.
- Geovax Labs (NASDAQ:GOVX) shares rose 7.81% to $0.81. Today's trading volume for this security ended up closing at 1.3 million shares, which is 70.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $21.3 million.
- Marker Therapeutics (NASDAQ:MRKR) shares rose 7.05% to $0.38. The market value of their outstanding shares is at $31.5 million.
- Tango Therapeutics (NASDAQ:TNGX) stock rose 5.26% to $7.2. The company's market cap stands at $634.8 million.
- China SXT Pharmaceuticals (NASDAQ:SXTC) stock moved upwards by 5.25% to $0.57. The market value of their outstanding shares is at $1.5 million.
Losers
- AnPac Bio-Medical Science (NASDAQ:ANPC) stock fell 9.9% to $8.0 during Thursday's after-market session. The company's market cap stands at $326.2 million.
- Syros Pharmaceuticals (NASDAQ:SYRS) stock decreased by 7.02% to $4.11. At the close, Syros Pharmaceuticals's trading volume reached 491.7K shares. This is 463.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $83.1 million.
- Minerva Surgical (NASDAQ:UTRS) shares declined by 5.21% to $0.41. At the close, Minerva Surgical's trading volume reached 9.4 million shares. This is 852.6% of its average volume over the last 100 days. The company's market cap stands at $12.2 million.
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock fell 5.19% to $1.83. Trading volume for this security closed at 422.4K, accounting for 18.1% of its average full-day volume over the last 100 days. The company's market cap stands at $5.6 million.
- Unicycive Therapeutics (NASDAQ:UNCY) shares fell 5.02% to $0.58. The market value of their outstanding shares is at $8.7 million.
- Jasper Therapeutics (NASDAQ:JSPR) stock declined by 5.01% to $1.71. The company's market cap stands at $63.3 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.